Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dart

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Journal of the American Medical Informatics Association : JAMIA|August 8, 2016
Evaluating electronic health record data sources and algorithmic approaches to identify hypertensive individualsPedro L Teixeira, Wei-Qi Wei, Robert M Cronin, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 5, 2013
Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
Physiological Genomics|February 3, 2005
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American populationMohammed S Orloff, Sudha K Iyengar, Cheryl A Winkler, et al.
Circulation|October 5, 2011
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)Linda B Piller, Sarah Baraniuk, Lara M Simpson, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2007
NPHS2 variation in sporadic focal segmental glomerulosclerosisLouise M McKenzie, Sher L Hendrickson, William A Briggs, et al.
Oncogene|May 3, 2019
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancerClaire E Fletcher, Eric Sulpice, Stephanie Combe, et al.
Nature Genetics|September 17, 2008
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisJeffrey B Kopp, Michael W Smith, George W Nelson, et al.
Journal of Cardiovascular Translational Research|July 22, 2015
A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) NetworkSuzette J Bielinski, Jyotishman Pathak, David S Carrell, et al.
Journal of the American College of Cardiology|May 13, 2026
Blood Pressure Assessment Across the Lifespan: Improving Clinical Research and Clinical Practice: A National Heart, Lung, and Blood Institute Workshop ReportMarwah Abdalla, Stephen P Juraschek, Italo Biaggioni, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of the American Medical Informatics Association : JAMIA|August 8, 2016
Evaluating electronic health record data sources and algorithmic approaches to identify hypertensive individualsPedro L Teixeira, Wei-Qi Wei, Robert M Cronin, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 5, 2013
Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)Karen L Margolis, Barry R Davis, Charles Baimbridge, et al.
Physiological Genomics|February 3, 2005
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American populationMohammed S Orloff, Sudha K Iyengar, Cheryl A Winkler, et al.
Circulation|October 5, 2011
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)Linda B Piller, Sarah Baraniuk, Lara M Simpson, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2007
NPHS2 variation in sporadic focal segmental glomerulosclerosisLouise M McKenzie, Sher L Hendrickson, William A Briggs, et al.
Oncogene|May 3, 2019
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancerClaire E Fletcher, Eric Sulpice, Stephanie Combe, et al.
Nature Genetics|September 17, 2008
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisJeffrey B Kopp, Michael W Smith, George W Nelson, et al.
Journal of Cardiovascular Translational Research|July 22, 2015
A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) NetworkSuzette J Bielinski, Jyotishman Pathak, David S Carrell, et al.
Journal of the American College of Cardiology|May 13, 2026
Blood Pressure Assessment Across the Lifespan: Improving Clinical Research and Clinical Practice: A National Heart, Lung, and Blood Institute Workshop ReportMarwah Abdalla, Stephen P Juraschek, Italo Biaggioni, et al.
Pageof 11